Loading Doses in NSTEMI for Elderly Patients
For elderly patients with NSTEMI, administer aspirin 162-325 mg loading dose immediately, followed by clopidogrel 300 mg loading dose (NOT 600 mg) or ticagrelor 180 mg loading dose, with appropriate anticoagulation (enoxaparin 1 mg/kg SC every 12 hours or fondaparinux 2.5 mg SC daily), and initiate high-intensity statin therapy as early as possible. 1, 2, 3, 4, 5
Aspirin Loading
- Loading dose: 162-325 mg non-enteric coated aspirin administered orally (chewed when possible for faster absorption) 1, 3, 4, 5
- Maintenance: 75-100 mg daily (NOT 81-325 mg) - the most recent 2025 ACC/AHA guidelines specifically recommend 75-100 mg daily, which represents a shift toward lower maintenance dosing 4
- Administer immediately upon presentation regardless of invasive vs. conservative strategy 3, 4
P2Y12 Inhibitor Selection in Advanced Age
Critical age-specific considerations:
Clopidogrel (Preferred in elderly ≥75 years)
- Loading dose: 300 mg (NOT 600 mg in elderly) 1, 6
- Maintenance: 75 mg daily 1, 3, 5
- This is the safest choice for patients ≥75 years when prasugrel and ticagrelor have contraindications or concerns 2, 5
Ticagrelor (Alternative option)
- Loading dose: 180 mg 2, 3, 4, 5
- Maintenance: 90 mg twice daily 2, 3, 5
- Can be used in elderly patients but requires careful monitoring 2
- Must use with low-dose aspirin (75-100 mg daily, NOT higher doses) 4, 5
Prasugrel (Generally NOT Recommended ≥75 years)
- Prasugrel is generally NOT recommended for patients ≥75 years due to increased risk of fatal and intracranial bleeding with uncertain benefit 1, 2, 1, 7
- Exception: May consider in very high-risk situations (diabetes + prior MI) with reduced dose of 5 mg daily maintenance (after 60 mg loading dose) 1, 2, 7, 4
- Absolute contraindications: prior stroke/TIA, active bleeding 2, 7
- Also avoid if body weight <60 kg (use 5 mg maintenance if must use) 1, 7
Anticoagulation Loading
Choose ONE of the following:
Enoxaparin (Class I, Level A)
- Loading: 30 mg IV bolus 1, 3
- Maintenance: 1 mg/kg SC every 12 hours 1, 3
- Dose adjustment for elderly with renal impairment:
- Critical: Calculate CrCl in all elderly patients as serum creatinine alone is unreliable 3
Fondaparinux (Class I, Level B)
- Dose: 2.5 mg SC daily 1, 3
- Contraindicated if CrCl <30 mL/min 1, 3
- Important: Must add UFH bolus at time of PCI (catheter thrombosis risk) 1, 3
UFH (Class I, Level B)
- Loading: 60 IU/kg IV bolus (max 4,000 IU) 1, 3
- Infusion: 12 IU/kg/hour (max 1,000 IU/hour) 1, 3
- Adjust to therapeutic aPTT 1, 3
Bivalirudin (Class I, Level B)
- Loading: 0.10 mg/kg 1, 3
- Infusion: 0.25 mg/kg/hour 1, 3
- For early invasive strategy only 1, 3
- Dose adjustment: CrCl <30 mL/min: 1 mg/kg/hour 3
Statin Loading
- Start high-intensity statin therapy immediately upon presentation 2, 5
- Continue long-term unless contraindicated 2
- No specific loading dose mentioned in guidelines, but initiate as early as possible 2
Critical Pitfalls in Elderly Patients
Bleeding Risk Considerations
- Elderly patients have 3-fold higher bleeding risk but also higher ischemic risk 1, 3
- The cardiovascular risk remains three times higher than bleeding risk even in elderly 8
- Highest risk period: first month after NSTEMI for both bleeding and ischemic events 8
Renal Function
- Must calculate CrCl - serum creatinine decreases 0.7 mL/min per year with age and does not reflect true renal function 3
- Adjust enoxaparin, fondaparinux, and bivalirudin doses based on CrCl 1, 3
Drug Interactions
- Avoid prasugrel if prior stroke/TIA (Class III Harm) 2, 7, 9
- Monitor for increased bleeding with concomitant NSAIDs, warfarin 3, 7
- Proton pump inhibitors may reduce clopidogrel effectiveness 3
Timing Considerations
- Aspirin: Immediately upon presentation 3, 4
- P2Y12 inhibitor: As soon as possible after presentation 3, 4, 5
- Anticoagulation: At time of diagnosis, continue through hospitalization or until PCI 1, 3
- Statin: As early as possible 2, 5
Special Situations
If Unable to Take Oral Medications
- Aspirin: Consider rectal or IV administration 4
- P2Y12 inhibitor: Consider cangrelor IV (if available and undergoing PCI) 5